Mycosis Fungoides, JAK Inhibitors, BCC & More | June 24, 2026 | Ep. 82, Issue 112

Join host Supriya Muppala and dive sk(in depth) into the latest dermatology research across medical, cosmetic, pediatric, and procedural dermatology.This week’s highlights include:Adult hypopigmented mycosis fungoides and its long-term clinical outcomesImmune checkpoint inhibitor-associated autoimmune bullous diseaseMicrobiota-fibroblast crosstalk in skin barrier dysfunction and fibrosisTopical JAK inhibitors for pediatric atopic dermatitisDermoscopic and confocal criteria for basal cell carcinoma subtypesRhytidectomy outcomes in patients with prior facial injectablesBellafill as a regenerative biomaterialPlus, a Student Spotlight on Chester Tyson, a medical student from the University of North Carolina and his review on species-specific antifungal therapy for pediatric tinea capitisWe’re also introducing Beyond the Abstract, a new segment going behind the scenes of dermatology research, and wrapping up with a Dermoscopy Question of the Week.All studies discussed are linked above. For questions, comments or future episode suggestions, please email us at [email protected] with sk(in depth):Website: ⁠⁠⁠⁠⁠⁠⁠https://www.skindepthderm.com/subscribe.html⁠⁠⁠⁠⁠⁠⁠Instagram: @skindepthdermX: @skindepth_derm-Music Credits: Tropical Vibe by WinnieTheMoogLink: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/song/10446-tropical-vibe⁠⁠⁠⁠⁠⁠⁠License: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license